Concurrent Sessions

Wednesday, September 23

8:00 am-12:25 pm

Antiplatelet Agent Utilization and Resistance

8:00 am-12:00 pm

IVUS Guidance in the DES Era: Emerging Studies and Case Tutorials

8:00 am-12:00 pm

Septal Occluders, Plugs, and Left Atrial Appendage Closure

2:00 pm-6:00 pm

Coronary Stent Design and Device Development

2:00 pm-6:10 pm

STEMI I. Optimizing Primary PCI Outcomes

2:00 pm-5:45 pm

Plaque Modification and Debulking in the Coronary and Peripheral Circulations: Atherectomy, Cutting Balloons, and Laser

2:00 pm-6:15 pm

CT, MR, and Nuclear Cardiovascular Imaging: Clinical Decision Making

Thursday, September 24

8:00 am-12:25 pm

Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents

8:00 am-12:00 pm

FFR and Physiologic Lesion Guidance: A User's Guide

8:00 am-12:00 pm

Microcirculatory Protection and Thrombectomy Devices in the Coronary and Peripheral Circulations

2:00 pm-5:20 pm

The Re-Emergence of Nitinol Self-Expanding Coronary Stents

2:00 pm-6:00 pm

Balancing Safety and Efficacy of Antithrombotic Therapies for PCI and ACS

2:00 pm-6:00 pm

Featured Clinical Trials: First Report Investigations

2:00 pm-5:30 pm

Imaging Modalities for Valvular Heart Disease Diagnosis and Treatment

Friday, September 25

8:00 am-12:00 pm

The OCT Summit

8:00 am-12:15 pm

Optimizing Outcomes in Unstable Angina and NSTEMI

8:00 am-12:35 pm

Novel Transcatheter Valve Therapies Under Development

2:00 pm-5:50 pm

Femoral Access and Vascular Closure Devices

2:00 pm-6:05 pm

STEMI II. Current Practice and Future Directions

2:00 pm-5:45 pm

Cath Lab of the Future